Crane Co. Aktie News

The first quarter of the 2024 earnings season has kicked off. This quarter is typically regarded as giving investors the initial pulse of the economy for the rest of the year.

Crane Company (NYSE:CR ) Q1 2024 Earnings Conference Call April 23, 2024 10:00 AM ET Company Participants Jason Feldman - Vice President, Treasury & Investor Relations Max Mitchell - President & Chief Executive Officer Richard Maue - Executive Vice President & Chief Financial Officer Conference Call Participants Matt Summerville - D.A. Davidson Scott Deuschle - Deutsche Bank Nathan Jones - Stif...

STAMFORD, Conn.--(BUSINESS WIRE)--Crane Company ("Crane," NYSE: CR) today announced its financial results for the first quarter of 2024 and updated its full-year outlook. Max Mitchell, Crane's Chairman, President and Chief Executive Officer, stated: “Crane is off to a great start in 2024, with strong results reflecting continued differentiated execution and accelerating results from growth init...

STAMFORD, Conn.--(BUSINESS WIRE)--Crane Company (NYSE: CR) announces the following schedule and teleconference information for its first quarter 2024 earnings release: Earnings Release: April 22, 2024 after close of market by public distribution and the Crane Company website at www.craneco.com. Teleconference: April 23, 2023 at 10:00 AM (Eastern) hosted by Max H. Mitchell, President & CEO, and ...

STAMFORD, Conn.--(BUSINESS WIRE)--Crane Company (NYSE: CR) will hold its annual investor conference on Tuesday, May 14, 2024, from 8:30 AM to 12:00 PM in New York City. Speakers will include Max H. Mitchell and other key Crane Company executives. Presentations will be available via live webcast. A web replay will be available on our website shortly after completion of the event. If you are inte...

The global economy is taking a turn this quarter, with the United States and China leading the way. After reporting a year of consecutive contraction, the U.S. manufacturing sector has finally pushed out its first expansionary reading during March 2024.

BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the 2023 annual results as of 31 December 2023. Financial Highlights Revenue increased by 18.1% to RMB738.5 million in 2023, including RMB670.7 million from orelabrutinib, an increase of 18.5%, mainly due to the continuous and rapi...

Crane Company (CR) Q4 2023 Earnings Call Transcript